Tweenvest Stocks

Teleflex Incorporated (NYSE: TFX)

Health Care · Health Care Equipment & Supplies · US

$137.10

-2.20% today · +9.9% 1Y

Teleflex Incorporated (NYSE: TFX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $5.94B and employs 15,500 people.

Over the last twelve months the share price has gained 9.9%, trading between 100.18 and 145.00.

Tweenvest scores Teleflex Incorporated across four factors: quality 61/100, value 52/100, growth 5/100, dividend 32/100. Its strongest factor is quality.

TFX price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$5.94B
Revenue (TTM)
$2.25B
P/E
EPS
-23.41
Dividend yield
0.98%
Beta (5Y)
0.81
52-week high
$145.00
52-week low
$100.18
Avg volume (3M)
Shares outstanding
42.37M
Employees
15,500
Next earnings

About Teleflex Incorporated

Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.

ISIN
US8793691069
Founded
1943
Listed since
Mar 17, 1980
Exchange
New York Stock Exchange
Currency
USD
CompanyMarket capPriceDay
Abbott LaboratoriesNYSE: ABT$200.95B$115.55-0.50%
Intuitive Surgical, Inc.NasdaqGS: ISRG$131.36B$369.41-0.65%
Stryker CorporationNYSE: SYK$126.81B$330.85+0.08%
Medtronic plcNYSE: MDT$116.66B$91.30+0.18%
EssilorLuxottica Société anonymeENXTPA: EL$85.36B160.65+0.94%
Boston Scientific CorporationNYSE: BSX$72.26B$47.77-4.19%
HOYA CorporationTSE: 7741$52.49B¥24,995.00+0.40%
Edwards Lifesciences CorporationNYSE: EW$52.38B$90.53-0.37%

Browse every Health Care Equipment & Supplies company →

Figures last refreshed Aug 18, 2026.